[1]苏 醒.前列地尔联合贝前列素钠治疗糖尿病周围神经病变的临床疗效及对其肢体症状的影响[J].医学信息,2025,38(02):136-139.[doi:10.3969/j.issn.1006-1959.2025.02.026]
　SU Xing.Clinical Efficacy of Alprostadil Combined with Beraprost Sodium in the Treatment of Diabetic Peripheral Neuropathy and its Effect on Limb Symptoms[J].Journal of Medical Information,2025,38(02):136-139.[doi:10.3969/j.issn.1006-1959.2025.02.026]
点击复制

前列地尔联合贝前列素钠治疗糖尿病周围神经病变的临床疗效及对其肢体症状的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
38卷
期数:
2025年02期
页码:
136-139
栏目:
论著
出版日期:
2025-01-15

文章信息/Info

Title:
Clinical Efficacy of Alprostadil Combined with Beraprost Sodium in the Treatment of Diabetic Peripheral Neuropathy and its Effect on Limb Symptoms
文章编号:
1006-1959（2025）02-0136-04
作者:
苏 醒
铅山县中医院内一科，江西 铅山 334500
Author(s):
SU Xing
The First Department of Internal Medicine, Yanshan County Hospital of Traditional Chinese Medicine, Yanshan 334500, Jiangxi, China
关键词:
前列地尔; 贝前列素钠; 糖尿病周围神经病变; 肢体症状; 神经功能受损; 血液流变学
Keywords:
Alprostadil;  Beraprost sodium;  Diabetic peripheral neuropathy;  Limb symptom;  Neurological impairment;  Hemorheology
分类号:
R587
DOI:
10.3969/j.issn.1006-1959.2025.02.026
文献标志码:
A
摘要:
目的 研究糖尿病周围神经病变患者应用前列地尔与贝前列素钠联合治疗的临床疗效及对其肢体症状的影响。方法 采用随机数字表法将铅山县中医医院2021年3月-2023年7月收治的72例糖尿病周围神经病变患者分成对照组36例和研究组36例。对照组应用前列地尔治疗，研究组应用贝前列素钠和前列地尔联合治疗。比较两组临床疗效、神经传导速度[运动神经传导速度（MNCV）和感觉神经传导速度（SNCV）]、神经功能受损程度（TCSS评分）、血液流变学指标（血浆黏度、全血黏度低切、全血黏度高切）、肢体症状。结果 研究组临床总有效率为94.44%，高于对照组的63.89%（P＜0.05）；两组治疗后正中神经、腓总神经MNCV、SNCV均快于治疗前，且研究组快于对照组（P＜0.05）；两组治疗后TCSS各项目评分、肢体症状各项目评分低于治疗前，且研究组低于对照组（P＜0.05）；两组治疗后血浆黏度、全血黏度低切、全血黏度高切水平低于治疗前，且研究组低于对照组（P＜0.05）。结论 前列地尔联合贝前列素钠治疗糖尿病周围神经病变的临床疗效确切，能够改善患者血液流变学指标，减轻患者肢体症状，提高患者神经功能。
Abstract:
Objective To study the clinical efficacy of alprostadil combined with beraprost sodium in patients with diabetic peripheral neuropathy and its effect on limb symptoms. Methods A total of 72 patients with diabetic peripheral neuropathy admitted to Yanshan County Hospital of Traditional Chinese Medicine from March 2021 to July 2023 were divided into control group (36 patients) and study group (36 patients) by random number table method. The control group was treated with alprostadil, and the study group was treated with beraprost sodium and alprostadil. The clinical efficacy, nerve conduction velocity [motor nerve conduction velocity (MNCV) and sensory nerve conduction velocity (SNCV)], neurological impairment (TCSS score), hemorheological indexes (plasma viscosity, whole blood viscosity low shear, whole blood viscosity high shear) and limb symptoms were compared between the two groups. Results The total clinical effective rate of the study group was 94.44%, which was higher than 63.89% of the control group (P<0.05). After treatment, MNCV and SNCV of median nerve and common peroneal nerve in the two groups were faster than those before treatment, and those in the study group were faster than those in the control group (P<0.05). After treatment, the scores of TCSS and limb symptoms in the two groups were lower than those before treatment, and those in the study group were lower than those in the control group (P<0.05). After treatment, the levels of plasma viscosity, whole blood viscosity low shear and whole blood viscosity high shear in the two groups were lower than those before treatment, and those in the study group were lower than those in the control group (P<0.05). Conclusion Alprostadil combined with beraprost sodium has a definite clinical effect in the treatment of diabetic peripheral neuropathy, which can improve the hemorheological indexes, relieve the limb symptoms and improve the neurological function of patients.

参考文献/References:

[1]杨娜.滋水清肝饮加减联合前列地尔对肝肾阴虚型糖尿病周围神经病变患者氧化应激损伤及肝肾功能的影响[J].现代中西医结合杂志,2021,30(6):635-638.[2]山永仪,李舜君,李冬萍,等.前列地尔联合马来酸桂哌齐特对2型糖尿病并发周围神经病变患者的临床疗效及对神经传导速度、氧化应激指标、胱抑素C水平的影响[J].中国老年学杂志,2020,40(7):1390-1393.[3]赵丹,周雪.α-硫辛酸联合前列地尔对2型糖尿病周围神经病变患者肌电图、血液流变学及血清炎症因子的影响[J].医学综述,2020,26(21):4354-4359.[4]孟影,刘晓蓉.前列地尔注射液联合甲钴胺注射液治疗糖尿病周围神经病变的疗效及对ABI、同型半胱氨酸的影响[J].湖南师范大学学报(医学版),2021,18(4):205-207.[5]王寒啸,林爱萍.前列地尔联合不同剂量鼠神经生长因子在糖尿病周围神经病变中的应用评价[J].中国医师进修杂志,2023,46(2):136-140.[6]李建树,张完美.活络通痹汤足浴联合前列地尔治疗糖尿病周围神经病变疗效及对氧化应激指标、胱抑素C水平的影响[J].现代中西医结合杂志,2018,27(25):2772-2775.[7]张利红,毛培军,徐永妮,等.前列地尔联合α-硫辛酸对糖尿病周围神经病变患者神经传导速度及氧化应激的影响[J].中国临床保健杂志,2020,23(3):373-376.[8]龚承岚,许艳美.甲钴胺联合前列地尔治疗糖尿病周围神经病变对血液流变学及神经电生理指标的影响[J].医药论坛杂志,2019,40(12):153-155.[9]毛春谱,张晓乐,刘春燕,等.α-硫辛酸联合前列地尔对糖尿病周围神经病变患者血清炎症因子及神经传导速度的影响[J].现代生物医学进展,2018,18(23):4497-4501.[10]王晓敏,沈利兰,何柏林,等.前列地尔联合依帕司他和甲钴胺治疗2型糖尿病周围神经病变的临床研究[J].中国基层医药,2018,25(13):1700-1703.[11]贾莹,谢瑾,贾艳芳.凯时联用甲钴胺及α-硫辛酸对糖尿病周围神经病变患者神经电生理与氧化应激的影响[J].中国药业,2018,27(16):46-49.[12]张俊蓉.硫辛酸联合前列地尔治疗2型糖尿病周围神经病变的临床疗效和安全性分析[J].中国药物与临床,2019,19(4):585-587.[13]杨曼,李奕平,杨莹,等.多伦多临床神经病变评分在2型糖尿病周围神经病变筛查中的应用及对临床治疗的评价[J].昆明医科大学学报,2020,41(5):75-79.[14]李宏伟,张颖辉,岳国荣.参芪降糖胶囊治疗糖尿病周围神经病变疗效及对患者血清ET-1、IL-6、TNF-α水平的影响[J].陕西中医,2018,39(8):1084-1086,1090.[15]周建伟,王欣欣,郑玉英,等.中医综合方案治疗2型糖尿病远端对称性多发性周围神经病变(DSPN)的临床随机对照研究[J].四川中医,2019,37(9):50-53.[16]屈丽媛,何美男,范新钊,等.贝前列素钠改善糖尿病周围神经病变患者平衡功能的疗效观察[J].中华糖尿病杂志,2023,15(10):917-924.[17]康锦芬,李靖云,黄文森,等.贝前列素钠联合硫辛酸对糖尿病周围神经病变患者TCSS评分、MDNS评分及神经传导速度的影响[J].川北医学院学报,2019,34(2):190-193.[18]李洁,安丽,任利群.贝前列素钠治疗老年糖尿病周围神经病变患者的临床疗效及对血清一氧化氮和内皮素-1水平的影响[J].中华老年医学杂志,2018,37(4):420-422.[19]徐杰,白婷,郭笑丹.丹参多酚酸盐联合贝前列素钠治疗对DPN患者血清胰岛素样生长因子-1、游离脂肪酸的影响[J].检验医学与临床,2022,19(2):231-234.[20]白如君,张虎,陈琦.灯盏花素联合贝前列素治疗糖尿病周围神经病变的临床效果及对血清高迁移率族蛋白B1和缺血修饰白蛋白水平的影响[J].中国医药,2022,17(1):64-67.

相似文献/References:

[1]周忠梅.前列地尔辅助常规治疗冠心病不稳定型心绞痛的效果及对患者凝血功能的影响[J].医学信息,2019,32(20):147.[doi:10.3969/j.issn.1006-1959.2019.20.046]
　ZHOU Zhong-mei.Effect of Alprostadil on Routine Treatment of Unstable Angina Pectoris in Coronary Heart Disease and its Effect on Coagulation Function in Patients[J].Journal of Medical Information,2019,32(02):147.[doi:10.3969/j.issn.1006-1959.2019.20.046]
[2]吴 飞,余 路.尿毒清颗粒及前列地尔联合丹参酮治疗糖尿病肾病的疗效[J].医学信息,2019,32(13):153.[doi:10.3969/j.issn.1006-1959.2019.13.048]
　WU Fei,YU Lu.Therapeutic Effect of Urinary Granules and Alprostadil Combined with Tanshinone on Diabetic Nephropathy[J].Journal of Medical Information,2019,32(02):153.[doi:10.3969/j.issn.1006-1959.2019.13.048]
[3]王 力,袁志强,黄晓鹏,等.前列地尔联合缬沙坦对慢性肾小球肾炎患者肾功能指标的影响[J].医学信息,2019,32(21):147.[doi:10.3969/j.issn.1006-1959.2019.21.048]
　WANG Li,YUAN Zhi-qiang,HUANG Xiao-peng,et al.Effect of Alprostadil Combined with Valsartan on Renal Function Indexes in Patients with Chronic Glomerulonephritis[J].Journal of Medical Information,2019,32(02):147.[doi:10.3969/j.issn.1006-1959.2019.21.048]
[4]张梓宸.前列地尔治疗冠心病心绞痛的疗效[J].医学信息,2020,33(01):149.[doi:10.3969/j.issn.1006-1959.2020.01.048]
　ZHANG Zi-chen.Effect of Alprostadil in the Treatment of Coronary Heart Disease and Angina Pectoris[J].Journal of Medical Information,2020,33(02):149.[doi:10.3969/j.issn.1006-1959.2020.01.048]
[5]姜 博,刘 艳.贝前列素钠辅助治疗对偏头痛患者血浆5-HT、β-EP、NT水平的影响[J].医学信息,2020,33(13):154.[doi:10.3969/j.issn.1006-1959.2020.13.046]
　JIANG Bo,LIU Yan.Effect of Adjuvant Therapy with Beraprost Sodium on Plasma 5-HT,β-EP and NT Levels in Migraine Patients[J].Journal of Medical Information,2020,33(02):154.[doi:10.3969/j.issn.1006-1959.2020.13.046]
[6]袁 娟,赫英龙.参芎葡萄糖与前列地尔治疗慢性肾脏病的疗效比较[J].医学信息,2020,33(14):163.[doi:10.3969/j.issn.1006-1959.2020.14.053]
　YUAN Juan,HE Ying-long.Comparison of Curative Effect between Shenqiong Glucose and Alprostadil in Treating Chronic Kidney Disease[J].Journal of Medical Information,2020,33(02):163.[doi:10.3969/j.issn.1006-1959.2020.14.053]
[7]陈钰泱,石爱杰.缬沙坦联合前列地尔治疗慢性肾小球肾炎的效果[J].医学信息,2020,33(15):151.[doi:10.3969/j.issn.1006-1959.2020.15.048]
　CHEN Yu-yang,SHI Ai-jie.The Effect of Valsartan Combined with Alprostadil on Chronic Glomerulonephritis[J].Journal of Medical Information,2020,33(02):151.[doi:10.3969/j.issn.1006-1959.2020.15.048]
[8]王 楠.前列地尔联合丁苯肽对缺血性脑卒中患者血清炎症因子及凝血功能的影响[J].医学信息,2021,34(12):169.[doi:10.3969/j.issn.1006-1959.2021.12.046]
　WANG Nan.Effects of Alprostadil Combined with Butylphthalide on Serum Inflammatory Factors and Coagulation Function in Patients with Ischemic Stroke[J].Journal of Medical Information,2021,34(02):169.[doi:10.3969/j.issn.1006-1959.2021.12.046]
[9]郭 婵.前列地尔对慢性肾功能衰竭患者血清炎症因子水平及营养生化指标的影响[J].医学信息,2022,35(13):146.[doi:10.3969/j.issn.1006-1959.2022.13.035]
　GUO Chan.Effect of Alprostadil on Serum Inflammatory Factors and Nutritional Biochemical Indexes in Patients with Chronic Renal Failure[J].Journal of Medical Information,2022,35(02):146.[doi:10.3969/j.issn.1006-1959.2022.13.035]

更新日期/Last Update: 1900-01-01